Oasis Management CO Ltd. Solid Biosciences Inc. Transaction History

Oasis Management CO Ltd.

  • $444 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.51 - $7.56 $294,576 - $4.37 Million
577,600 Added 259.71%
800,000 $373,000
Q2 2022

Aug 15, 2022
BUY
$0.43 - $1.24 $95,632 - $275,776
222,400 New
222,400 $137,000

Others Institutions Holding SLDB

# of Institutions
2
Shares Held
97
Call Options Held
0
Put Options Held
0
View Full List

About Solid Biosciences Inc.

SLDB Quotes by TradingView
  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $53.2M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Oasis Management CO Ltd. Portfolio

Follow Oasis Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oasis Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Oasis Management CO Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email